Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» UBS downgrades Arena to 'Neutral' on risk-reward for obesity drug program, shares tumble
UBS downgrades Arena to 'Neutral' on risk-reward for obesity drug program, shares tumble
UBS downgrades Arena to 'Neutral' on risk-reward for obesity drug program, shares tumble
Submitted by
admin
on February 18, 2009 - 1:35pm
Source:
Yahoo/AP
News Tags:
Arena Pharmaceuticals
obesity
Headline:
UBS downgrades Arena to 'Neutral' on risk-reward for obesity drug program, shares tumble
Do Not Allow Advertisers to Use My Personal information
